{"id":48260,"date":"2022-09-12T17:02:07","date_gmt":"2022-09-12T15:02:07","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-bph-treatment-device-medcore-market-report-2022-size-share-covid-19-impact-analysis-procedure-numbers-unit-sales-average-selling-prices-market-value-growth-trends-researchandmarket\/"},"modified":"2022-09-12T17:02:07","modified_gmt":"2022-09-12T15:02:07","slug":"global-bph-treatment-device-medcore-market-report-2022-size-share-covid-19-impact-analysis-procedure-numbers-unit-sales-average-selling-prices-market-value-growth-trends-researchandmarket","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-bph-treatment-device-medcore-market-report-2022-size-share-covid-19-impact-analysis-procedure-numbers-unit-sales-average-selling-prices-market-value-growth-trends-researchandmarket\/","title":{"rendered":"Global BPH Treatment Device MedCore Market Report 2022: Size, Share & COVID-19 Impact Analysis – Procedure Numbers, Unit Sales, Average Selling Prices, Market Value & Growth Trends – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “BPH Treatment Device Market Size, Share & COVID-19 Impact Analysis | Global | 2022-2028 | MedCore”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe total global BPH treatment device market is growing at a rate of 5.2%, which will take the 2021 market value of $1.2 billion up to $1.7 billion by 2028.\n<\/p>\n

\nThe primary limiter of the BPH treatment device market is the increasing use of pharmaceutical treatments. In 2021, over 90% of BPH patients received drug therapy treatment over interventional methods.\n<\/p>\n

\nThe full report suite on the global market for benign prostatic hyperplasia (BPH) treatment devices includes transurethral resection of the prostate (TURP), laser BPH, UroLift and Rezum segments.\n<\/p>\n

\nThe TURP market is further segmented into monopolar and bipolar electrodes. The laser BPH market includes high-power Holmium equipment and dedicated fiber, as well as thulium equipment and fiber segments. The UroLift and Rezum markets are defined by consumables required for each of the procedure.\n<\/p>\n

\nGLOBAL BPH TREATMENT DEVICE MARKET TRENDS<\/strong>\n<\/p>\n

\nBoth Rezum and Urolift are relatively new treatments for BPH. They are both non-invasive procedures that are being adopted primarily in developed countries such as United States and in Western Europe. These markets are relatively new and many countries have not yet adopted these technologies. As countries begin reimbursing for these treatments, the market will grow significantly.\n<\/p>\n

\nGLOBAL BPH TREATMENT DEVICE MARKET SHARE INSIGHTS<\/strong>\n<\/p>\n

\nOverall, within the global BPH treatment device market there are three dominant competitors: Boston Scientific, Teleflex, and Olympus. In 2021, the leading competitor in the BPH treatment device market was Boston Scientific. The company held the dominant leading position in the laser BPH market and a monopolistic position in the Rezum market. The company held the second-leading share in North America and was the leading competitor in Western Europe and the rest of the world countries.\n<\/p>\n

\nMARKET SEGMENTATION SUMMARY<\/strong>\n<\/p>\n

\nYou can view all the included markets and segmentation here:\n<\/p>\n